New CEO backs Leo Pharma's transformation: "It is definitely the right strategy"
The new CEO of Leo Pharma is excited about the strategic direction at the company. This involves creating a more innovative portfolio, including eczema treatment tralokinumab, and she would like to accelerate the strategy further.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
It has been full-speed ahead when it comes to investments at Leo Pharma over the past few years, and that seems set to continue in 2020 and beyond.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
